Molecularly, PC is characterized by inactivating mutations in TP53, RB, CDKN1A, CDKN2A, or those associated to heritable PC such as BRCA1 and BRCA2 [56,57]. This evidence concerns the gene BRCA2 and pachyonychia congenita.